According to Zhitong Finance App, Zhaoke Ophthalmology-B (06622) announced that the company's production site in Nansha, Guangzhou, China recently obtained the Good Manufacturing Practice (GMP) certification issued by the Australian Therapeutic Goods Administration (TGA).

Australia is a full member of the International Pharmaceutical Inspection Co-operation Scheme (PIC/S), and its GMP inspection results are highly mutually recognized among PIC/S member agencies. TGA GMP certification marks the further recognition of the production and quality management system of the company's production facilities by an international drug regulatory agency. As various products continue to be registered and commercialized overseas, the company's production and quality management system that meets international regulatory requirements will provide important support for related products to enter more overseas markets in the future and for the company to continue to advance its global strategy.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.